Pathogenetic Tropism of Varicella-Zoster Virus to Primary Human Hepatocytes and Attenuating Tropism of Oka Varicella Vaccine Strain to Neonatal Dermal Fibroblasts

Journal of Infectious Diseases

Volumn 188, Issue 12, 2003, Pages 1875-1877

  Shiraki, Kimiyasu ^a   Yoshida, Yoshihiro ^a   Asano, Yoshizo ^b   Yamanishi, Koichi ^c   Takahashi, Michiaki ^d  

^a UNIVERSITY OF TOYAMA   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d Osaka University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ARTICLE; AUTOPSY; CONTROLLED STUDY; CORRELATION ANALYSIS; HEPATITIS; HUMAN; HUMAN CELL; LIVER CELL; LUNG FIBROBLAST; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; SKIN FIBROBLAST; VARICELLA ZOSTER VIRUS; VIROGENESIS; VIRUS REPLICATION;

CELLS, CULTURED; CHICKENPOX VACCINE; CYTOPATHOGENIC EFFECT, VIRAL; FIBROBLASTS; HEPATOCYTES; HERPESVIRUS 3, HUMAN; HUMANS; INFANT, NEWBORN; LUNG; SKIN; TROPISM;

EID: 0347950023     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/379835     Document Type: Article

References (15)

1. Whitely RJ. Varicella-zoster virus infections. In: Brunwald E, Hauser SL, Fauci AS, Longo DL, Kasper DL, Jameson SL, eds. Harrison's principles of internal medicine. 15th ed. New York: McGraw-Hill, 2001: 1108-10.
2. Myers MG, Stanberry LR. Varicella-zoster virus. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson textbook of pediatrics. 16th ed. Philadelphia: WB Saunders, 2000:973-7.
3. Gershon AA, Sears AE. Varicella-zoster virus infections. In: Krugman S, Katz SL, Gershon AA, Wilfert CM, eds. Infectious diseases of children. 9th ed. St. Louis: Mosby-Year Book, 1992:587-614.
4. Takahashi M. The varicella vaccine: vaccine development. Infect Dis Clin North Am 1996; 10:469-88.
5. Moffat JF, Zerboni L, Kinchington PR, Grose C, Kaneshima H, Arvin AM. Attenuation of the vaccine strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol 1998; 72:965-74.
6. Shiraki K, Yamanishi K, Takahashi M. Biologic and immunologic characterization of the soluble skin-test antigen of varicella-zoster virus. J Infect Dis 1984; 149:501-4.
7. Nikkels AF, Debrus S, Sadzot-Delvaux C, Piette J, Rentier B, Pierard GE. Localization of varicella-zoster virus nucleic acids and proteins in human skin. Neurology 1995; 45:547-9.
8. Grose C, Brunel PA. Varicella-zoster virus isolation and propagation in human melanoma cells at 36 and 32 degrees C. Infect Immun 1978; 19:199-203.
9. Asano Y, Yoshikawa T, Urisu A, Yazaki T, Mizoguchi Y, Kurata T. Varicella zoster virus replication sites in internal organs of an otherwise healthy child with varicella and sudden death. Acta Paediatr Jpn 1993; 35:348-51.
10. Weber DM, Pellecchia JA. Varicella pneumonia: study of prevalence in adult men. JAMA 1965; 192:572-3.
11. Feldman S, Lott L. Varicella in children with cancer: impact of antiviral therapy and prophylaxis. Pediatrics 1987; 80:465-72.
12. Schlossberg D, Littman M. Varicella pneumonia. Arch Intern Med 1988; 148:1630-2.
13. Feldman S, Crout ID, Andrew ME. Incidence and natural history of chemically defined varicella-zoster virus hepatitis in children and adolescents. Scand J Infect Dis 1997; 29:33-6.
14. Pitel PA, McCormick KL, Fitzgerald E, Orson JM. Subclinical hepatic changes in varicella infection. Pediatrics 1980; 65:631-3.
15. Hayakawa Y, Torigoe S, Shiraki K, Yamanishi K, Takahashi M. Biologic and biophysical markers of a live varicella vaccine strain (Oka): identification of clinical isolates from vaccine recipients. J Infect Dis 1984; 149:956-63.